You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb425934 |
---|---|
Category | Proteins |
Description | H1N1 New Caledonia protein |
Form/Appearance | Sterile Filtered colorless solution. |
Buffer/Preservatives | The H1N1 A/New Caledonia/20/99 IVR solution contains STE, 0.09% sodium azide (NaN3) and 0.005% thimerosal. |
Purity | Greater than 90.0% as determined by ELISA analysis. |
Application notes | Inactivation: Thimerosal and beta propiolactone treatmentThis product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work. Immunological Activity: Tested with anti-influenza A monoclonal antibodies in ELISA.Serological studies of influenza A virus, immunogen for antibody production |
Storage | Stability: A/New Caledonia/20/99 IVR although stable 4°C for 4 weeks, should be stored below -18°C. Please prevent freeze-thaw cycles |
Note | For research use only |
Expiration Date | 6 months from date of receipt. |
97.30% | |
59 kDa (predicted); 66-83 kDa (reducing condition, due to glycosylation) |
38 kDa (predicted); 50-60 kDa (reducing condition, due to glycosylation) |
>98%, determined by SDS-PAGE | |
This protein contains the influenza hemagglutinin (A/New Caledonia/20/99 (H1N1)) (Met 1-Gln 528) (AAP343241), (HA1+HA2, uncleaved) was fused with a C-terminal polyhistidine tag and expressed from HEK293 Cells. |
>95%, determined by SDS-PAGE | |
This protein contains the influenza hemagglutinin (A/New Caledonia/20/99 (H1N1)) (Met 1-Arg 343) (AAP343241), (termed as HA1) was fused with a C-terminal polyhistidine tag and expressed from HEK293 Cells. |